Physician profile
David Schweibish
NPI 1184007965
$8,214.22
in general payments reported to CMS, 2019-2025
27 companies · $559 in 2025
The $559 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,953 · 2020: $864 · 2022: $440 · 2023: $906 · 2024: $493 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,789 · Travel and Lodging: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,788.65 |
| Travel and Lodging | $169.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,017.33 | 2019-2025 | |
| Wright Medical Technology, INC. | $822.12 | 2019 | |
| Biotissue Holdings INC. | $781.40 | 2020 | |
| Stryker Corporation | $616.03 | 2019-2025 | Prostep, Ortholoc 3di, Citrefix |
| Paratek Pharmaceuticals, INC. | $499.65 | 2022-2025 | Nuzyra |
| Organogenesis INC. | $203.59 | 2019-2024 | Puraply |
| Alafair Biosciences, INC. | $161.92 | 2025 | Versawrap |
| Biocomposites INC | $160.85 | 2023 | Stimulan |
| Linvatec Corporation | $137.20 | 2025 | Biobrace 23mm, Neospan |
| Horizon Therapeutics Plc | $136.49 | 2019-2022 | |
| Cardiovascular Systems INC. | $126.08 | 2019 | |
| Amgen INC. | $98.85 | 2024 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $96.36 | 2023 | Jublia |
| Kci USA, INC. | $77.02 | 2019-2023 | V.A.C. Dermatac, Activ.A.C. |
| Amniox Medical, INC. | $29.35 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $28.59 | 2023-2025 | Physio-Stim |
| Abbott Laboratories | $27.82 | 2023 | Proclaim |
| Heron Therapeutics, INC. | $27.37 | 2022 | |
| Convatec INC. | $22.77 | 2023 | |
| Integra Lifesciences Corporation | $22.05 | 2019 | |
| Ermi LLC | $19.29 | 2020 | |
| Curonix LLC | $19.19 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kerecis Limited | $19.11 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ibsa Pharma INC. | $18.68 | 2023 | Tirosint, Licart |
| Medtronic, INC. | $17.07 | 2025 | Interstim |
| Cgg Medical INC | $15.77 | 2025 | |
| Smith+Nephew, INC. | $12.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schweibish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.